Mineralys to Present Long-Term Lorundrostat Data in November
RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) will present new long-term efficacy and safety data for lorundrostat in November, providing an additional clinical readout as the company advances the …
Mineralys to Present Long-Term Lorundrostat Data in November Read More